On-demand cleavable linkers for radioimmunotherapy

Pappanaicken R. Kumaresan, Juntao Luo, Kit Lam

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Radioimmunotherapy (RIT) using radiolabeled antibodies or its fragments holds great promise for cancer therapy. However, its clinical potential is often limited by the undesirable radiation exposure to normal organs such as liver, kidney, and bone marrow. It is important to develop new strategies in RIT that enable protection of vital organs from radiation exposure while maintaining therapeutic radiation dose to the cancer. One way to achieve this is to clear radiometal rapidly from the circulation after accumulation of radioimmunoconjugates (RIC) in the tumor. Our strategy is to place a highly efficient and specific cleavable linker between radiometal chelate and the tumor targeting agent. Such linker must be resistant to cleavage by enzymes present in the plasma and tumor. After radiotargeting agents have accumulated in the tumor, a cleaving agent (protease) can be administered to the patient "on demand" to cleave the specific linker, resulting in the release of radiometal from the circulating RIC, in a form that can be cleared rapidly by the kidneys. TNKase ®, a serine protease tissue plasminogen activator and thrombolytic agent, which has been approved for clinical use in patient with acute myocardial infarction, was selected as an on-demand cleaving agent in our model. TNKase ® specific on-demand cleavable (ODC) linkers were identified through screening random internally quenched fluorescent resonance energy transfer (FRET) "one-bead-one-compound" (OBOC) combinatorial peptide libraries. FRET-OBOC peptide libraries containing l-amino acid(s) in the center of the random linear peptide and d-amino acids flanking both sides of the l-amino acid(s) were used for screening. Peptide beads susceptible to TNKase ® but resistant to plasma and tumor-associated protease cleavage were isolated for sequence analysis. The focus of this chapter is on the methods that have been used to identify and characterize ODC linkers and protease-specific substrates.

Original languageEnglish (US)
Title of host publicationMethods in Molecular Biology
Pages191-211
Number of pages21
Volume539
DOIs
StatePublished - 2009

Publication series

NameMethods in Molecular Biology
Volume539
ISSN (Print)10643745

Fingerprint

Radioimmunotherapy
Neoplasms
Immunoconjugates
Peptide Library
Peptide Hydrolases
Energy Transfer
Amino Acids
Kidney
Peptides
Fibrinolytic Agents
Serine Proteases
Tissue Plasminogen Activator
Sequence Analysis
Bone Marrow
Myocardial Infarction
Radiation
Antibodies
Liver
Enzymes
Therapeutics

Keywords

  • Combinatorial chemistry
  • FRET-OBOC libraries
  • On-demand cleavable linkers
  • Protease substrates
  • Radioimmunotherapy

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Kumaresan, P. R., Luo, J., & Lam, K. (2009). On-demand cleavable linkers for radioimmunotherapy. In Methods in Molecular Biology (Vol. 539, pp. 191-211). (Methods in Molecular Biology; Vol. 539). https://doi.org/10.1007/978-1-60327-003-8_11

On-demand cleavable linkers for radioimmunotherapy. / Kumaresan, Pappanaicken R.; Luo, Juntao; Lam, Kit.

Methods in Molecular Biology. Vol. 539 2009. p. 191-211 (Methods in Molecular Biology; Vol. 539).

Research output: Chapter in Book/Report/Conference proceedingChapter

Kumaresan, PR, Luo, J & Lam, K 2009, On-demand cleavable linkers for radioimmunotherapy. in Methods in Molecular Biology. vol. 539, Methods in Molecular Biology, vol. 539, pp. 191-211. https://doi.org/10.1007/978-1-60327-003-8_11
Kumaresan PR, Luo J, Lam K. On-demand cleavable linkers for radioimmunotherapy. In Methods in Molecular Biology. Vol. 539. 2009. p. 191-211. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-60327-003-8_11
Kumaresan, Pappanaicken R. ; Luo, Juntao ; Lam, Kit. / On-demand cleavable linkers for radioimmunotherapy. Methods in Molecular Biology. Vol. 539 2009. pp. 191-211 (Methods in Molecular Biology).
@inbook{71575bf5b1684306b7cd356132ab6cf9,
title = "On-demand cleavable linkers for radioimmunotherapy",
abstract = "Radioimmunotherapy (RIT) using radiolabeled antibodies or its fragments holds great promise for cancer therapy. However, its clinical potential is often limited by the undesirable radiation exposure to normal organs such as liver, kidney, and bone marrow. It is important to develop new strategies in RIT that enable protection of vital organs from radiation exposure while maintaining therapeutic radiation dose to the cancer. One way to achieve this is to clear radiometal rapidly from the circulation after accumulation of radioimmunoconjugates (RIC) in the tumor. Our strategy is to place a highly efficient and specific cleavable linker between radiometal chelate and the tumor targeting agent. Such linker must be resistant to cleavage by enzymes present in the plasma and tumor. After radiotargeting agents have accumulated in the tumor, a cleaving agent (protease) can be administered to the patient {"}on demand{"} to cleave the specific linker, resulting in the release of radiometal from the circulating RIC, in a form that can be cleared rapidly by the kidneys. TNKase {\circledR}, a serine protease tissue plasminogen activator and thrombolytic agent, which has been approved for clinical use in patient with acute myocardial infarction, was selected as an on-demand cleaving agent in our model. TNKase {\circledR} specific on-demand cleavable (ODC) linkers were identified through screening random internally quenched fluorescent resonance energy transfer (FRET) {"}one-bead-one-compound{"} (OBOC) combinatorial peptide libraries. FRET-OBOC peptide libraries containing l-amino acid(s) in the center of the random linear peptide and d-amino acids flanking both sides of the l-amino acid(s) were used for screening. Peptide beads susceptible to TNKase {\circledR} but resistant to plasma and tumor-associated protease cleavage were isolated for sequence analysis. The focus of this chapter is on the methods that have been used to identify and characterize ODC linkers and protease-specific substrates.",
keywords = "Combinatorial chemistry, FRET-OBOC libraries, On-demand cleavable linkers, Protease substrates, Radioimmunotherapy",
author = "Kumaresan, {Pappanaicken R.} and Juntao Luo and Kit Lam",
year = "2009",
doi = "10.1007/978-1-60327-003-8_11",
language = "English (US)",
isbn = "9781603270021",
volume = "539",
series = "Methods in Molecular Biology",
pages = "191--211",
booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - On-demand cleavable linkers for radioimmunotherapy

AU - Kumaresan, Pappanaicken R.

AU - Luo, Juntao

AU - Lam, Kit

PY - 2009

Y1 - 2009

N2 - Radioimmunotherapy (RIT) using radiolabeled antibodies or its fragments holds great promise for cancer therapy. However, its clinical potential is often limited by the undesirable radiation exposure to normal organs such as liver, kidney, and bone marrow. It is important to develop new strategies in RIT that enable protection of vital organs from radiation exposure while maintaining therapeutic radiation dose to the cancer. One way to achieve this is to clear radiometal rapidly from the circulation after accumulation of radioimmunoconjugates (RIC) in the tumor. Our strategy is to place a highly efficient and specific cleavable linker between radiometal chelate and the tumor targeting agent. Such linker must be resistant to cleavage by enzymes present in the plasma and tumor. After radiotargeting agents have accumulated in the tumor, a cleaving agent (protease) can be administered to the patient "on demand" to cleave the specific linker, resulting in the release of radiometal from the circulating RIC, in a form that can be cleared rapidly by the kidneys. TNKase ®, a serine protease tissue plasminogen activator and thrombolytic agent, which has been approved for clinical use in patient with acute myocardial infarction, was selected as an on-demand cleaving agent in our model. TNKase ® specific on-demand cleavable (ODC) linkers were identified through screening random internally quenched fluorescent resonance energy transfer (FRET) "one-bead-one-compound" (OBOC) combinatorial peptide libraries. FRET-OBOC peptide libraries containing l-amino acid(s) in the center of the random linear peptide and d-amino acids flanking both sides of the l-amino acid(s) were used for screening. Peptide beads susceptible to TNKase ® but resistant to plasma and tumor-associated protease cleavage were isolated for sequence analysis. The focus of this chapter is on the methods that have been used to identify and characterize ODC linkers and protease-specific substrates.

AB - Radioimmunotherapy (RIT) using radiolabeled antibodies or its fragments holds great promise for cancer therapy. However, its clinical potential is often limited by the undesirable radiation exposure to normal organs such as liver, kidney, and bone marrow. It is important to develop new strategies in RIT that enable protection of vital organs from radiation exposure while maintaining therapeutic radiation dose to the cancer. One way to achieve this is to clear radiometal rapidly from the circulation after accumulation of radioimmunoconjugates (RIC) in the tumor. Our strategy is to place a highly efficient and specific cleavable linker between radiometal chelate and the tumor targeting agent. Such linker must be resistant to cleavage by enzymes present in the plasma and tumor. After radiotargeting agents have accumulated in the tumor, a cleaving agent (protease) can be administered to the patient "on demand" to cleave the specific linker, resulting in the release of radiometal from the circulating RIC, in a form that can be cleared rapidly by the kidneys. TNKase ®, a serine protease tissue plasminogen activator and thrombolytic agent, which has been approved for clinical use in patient with acute myocardial infarction, was selected as an on-demand cleaving agent in our model. TNKase ® specific on-demand cleavable (ODC) linkers were identified through screening random internally quenched fluorescent resonance energy transfer (FRET) "one-bead-one-compound" (OBOC) combinatorial peptide libraries. FRET-OBOC peptide libraries containing l-amino acid(s) in the center of the random linear peptide and d-amino acids flanking both sides of the l-amino acid(s) were used for screening. Peptide beads susceptible to TNKase ® but resistant to plasma and tumor-associated protease cleavage were isolated for sequence analysis. The focus of this chapter is on the methods that have been used to identify and characterize ODC linkers and protease-specific substrates.

KW - Combinatorial chemistry

KW - FRET-OBOC libraries

KW - On-demand cleavable linkers

KW - Protease substrates

KW - Radioimmunotherapy

UR - http://www.scopus.com/inward/record.url?scp=79958292210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958292210&partnerID=8YFLogxK

U2 - 10.1007/978-1-60327-003-8_11

DO - 10.1007/978-1-60327-003-8_11

M3 - Chapter

SN - 9781603270021

VL - 539

T3 - Methods in Molecular Biology

SP - 191

EP - 211

BT - Methods in Molecular Biology

ER -